Data as of Dec 24
| -0.06 / -0.20%|
The 8 analysts offering 12-month price forecasts for Sabra Health Care REIT Inc have a median target of 30.50, with a high estimate of 32.00 and a low estimate of 28.00. The median estimate represents a +0.83% increase from the last price of 30.25.
The current consensus among 10 polled investment analysts is to Buy stock in Sabra Health Care REIT Inc. This rating has held steady since December, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.